DA YU FIN (01073): Lai Yingzhen appointed as independent non-executive director.
Da Yu Finance (01073) announced that Mr. Sun Zhiwei resigned as an independent non-executive director, effective from the end of the annual general meeting of shareholders; Ms. Lai Yingzhen was formally appointed as an independent non-executive director.
DA YU FIN (01073) announced that Mr. Sun Zhiwei resigned as an independent non-executive director following the conclusion of the annual general meeting of shareholders; Ms. Lai Yingzhen has been formally appointed as an independent non-executive director.
Following Mr. Sun Zhiwei's resignation as an independent non-executive director and the appointment of Ms. Lai Yingzhen as an independent non-executive director, Mr. Sun Zhiwei will no longer serve as the chairman of the company's nomination committee, and as a member of the company's audit committee and remuneration committee; Ms. Lai Yingzhen will assume the role as chairman of the nomination committee, and as a member of the audit committee and remuneration committee; and the current executive director, Ms. Li Ming, will no longer serve as a member of the nomination committee, all of which will take effect following the conclusion of the 2026 annual general meeting of shareholders.
Related Articles

IMOTIONTECH (01274) spent 1.77 million Hong Kong dollars to repurchase 385,500 shares on May 22nd.

CSPC PHARMA (01093): Ulinastatin Injection Obtains Approval from National Medical Products Administration for Market Launch.

CSRC agrees to Superpure's application for IPO registration on the ChiNext board.
IMOTIONTECH (01274) spent 1.77 million Hong Kong dollars to repurchase 385,500 shares on May 22nd.

CSPC PHARMA (01093): Ulinastatin Injection Obtains Approval from National Medical Products Administration for Market Launch.

CSRC agrees to Superpure's application for IPO registration on the ChiNext board.






